Noticias

Noticias

  • Título: ARTICULO DE ANALISIS Y OPINION: Dr. Frank J. Criado "Current Views on Type II Endoleaks"
  • Fecha: 30-09-2013
  • ARTICULO DE ANALISIS Y OPINION:
    Dr. Frank J. Criado para endovascular.es

    As I fly home from London after participating in theCharing Cross Vascular Symposium (35th annual edition!) and begin to reviewprominent topics presented during theevent’s intense 3 days, it becomes clear that post-EVAR type II endoleaks areamong the top issues discussed, and a controversial issue at that! An entiresession was dedicated to this very topic.

    Although there is not much “new” to report, I didcome out with the distinct impression that

    management guidelines and outcome implication oftype II endoleaks may not be as clear as I

    thought they had become in recent years.

    Several noted experts in the EVAR field expressedreasoned doubt about the prevailing view that “type II endoleaks are benign,”advancing the concept that such endoleaks may well carry significant long-termpotential for AAA complications and theneed for reinterventions. Attention went also to the detection of theseendoleaks and how in some cases their true nature can be masked or confusedwhen there is a concomitant type I or III endoleak.

    In the end I believe we can safely adhere to theprevailing current view that most type II endoleaks behave in a benign mannerand need not be considered for intervention and closure unless they areaccompanied by a minimum 5 mm annual sac growth.

    However, we must strive to ascertain their truenature in every case, and exclude the more dangerous high-pressure types I andIII.

    We can also look forward to interesting newdevelopments in the foreseeable future, mainly the anticipated availability ofthe Endologix Nellix “aneurysm sealing system” that promises to nearlyeliminate type II endoleaks as the aneurysm sac is completely sealed with two polymer-filledultrathin polyester endobags. Stay tuned.




  • Fuente: endovascular.es